Additionally, the survival advantage was observed regardless of prior systemic therapy, though it did not reach statistical significance in treatment-naïve patients.
← all excerpts
Genetic and transcriptional insights into immune checkpoint blockade response and survival: lessons from melanoma and beyond.
1
—
—